For patients with early-stage cervical cancer, sentinel lymph node biopsy alone is noninferior to lymphadenectomy with respect to disease-free survival, according to a study published online Oct. 15 ...

A genomic test co-developed by Mayo Clinic and SkylineDx can identify whether people with melanoma are at low or high risk ...

In patients with early-stage acral melanoma, upper-limb tumors tend to spread first to distant organs, whereas lower-limb tumors are more likely to metastasize first to lymph nodes.

From blood tests that predict recurrence to smarter, less invasive treatments, 2025 is delivering real hope—especially for ...

MONDAY, Oct. 27, 2025 (HealthDay News) — An already-available genetic test might spare some melanoma patients from a surgical ...

A gene expression profile-based test can spot melanoma patients who have a low risk of cancer spreading to their lymph nodes.

Of patients identified as low risk by combined clinicopathological factors and GEP test, only 7.1% were SLN-positive.

A genomic test co-developed by Mayo Clinic and SkylineDx can identify whether people with melanoma are at low or high risk for cancer in their lymph ...

Early detection, advanced drug therapies, and less invasive surgeries are transforming breast cancer care, offering better ...

Following her diagnosis, Emily Rockefeller is advocating for making cancer screenings more routine in prenatal genetic ...

SkylineDx today announced that results from its landmark MERLIN_001 trial, the largest prospective evaluation of a genomic test in cutaneous melanoma, have been published in the October 2025 issue of ...